Eli Lilly Launches New Site to Access Clinical Trial DataBy
Eli Lilly and Company will begin sharing its clinical trial data with scientific researchers through www.clinicalstudydatarequest.com. This website, which houses data from several clinical trial sponsors, was created in support of ongoing efforts by the
The new portal, www.clinicalstudydatarequest.com, differs from previous Lilly data-sharing sites in that access will only be granted after approval of a research proposal by an independent scientific review panel. Lilly will not be involved in the decisions made by the independent scientific review panel.
The multi-sponsor portal will include Lilly-sponsored interventional clinical studies from approved medicines and indications in the United States and European Union (EU) in the following categories:
- Phase II, III, or IV studies used as part of a regulatory approval submitted to the FDA on or after 1999;
- Phase II, III, or IV global studies with a first patient visit after
January 1, 2007; and
- Phase II, III, or IV global or regional/local studies in indications approved in both the US and EU with a first patient visit after
January 1, 2014.
All shared data on the website are anonymized to safeguard patients’ privacy.
To increase open access and transparency, the company established www.lillyclinicalstudydata.com in
Lilly also provides information on and links to information about its clinical studies on www.LillyTrials.com. The website includes results of all Lilly-sponsored Phase II, Phase III, and Phase IV clinical trials as well as observational trials of Lilly-marketed products conducted anywhere in the world that were initiated on or after
Source: Eli Lilly